$SNTS News BHP as an example against contrarian investing

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 6:12 PM

$SNTS News

BHP as an example against contrarian investing 8:42 a.m. Aug. 20, 2013 - The Trading Deck
4 small caps set to surge 10:29 a.m. July 24, 2013 - The Trading Deck
Can this biotech double its price again? 7:02 a.m. July 17, 2013 - The Trading Deck
This is a market that wants to go up 12:32 p.m. July 9, 2013 - The Trading Deck
For the medium-term trader, setups galore 10:39 a.m. May 14, 2013 - The Trading Deck
Transparency: Filings reveal funds like Lululemon 11:22 a.m. April 17, 2013 - Insider Monkey
S&P 500 retests the breakout point 10:01 a.m. April 15, 2013 - Michael Ashbaugh
Slow-motion uptrend nears major resistance 10:12 a.m. March 13, 2013 - Michael Ashbaugh
Nasdaq clues suggest more upward valuation 12:46 p.m. March 8, 2013 - The Trading Deck
Stocks poised to top all-time closing high 9:23 a.m. March 5, 2013 - Kate Gibson
J.C. Penney, Impax shares drop after hours 6:46 p.m. March 4, 2013 - Carla Mozee
Santarus Q4 profit triples, offers upbeat view 5:50 p.m. March 4, 2013 - MarketWatch.com
Santarus shares resume trading, rise 12% 4:38 p.m. March 4, 2013 - Carla Mozee
13 stocks for ’13 6:16 p.m. Jan. 3, 2013 - The Trading Deck
Hot stocks to watch 6:31 a.m. Sept. 12, 2012 - MarketWatch.com
U.S. benchmarks violate the 200-day average 10:06 a.m. June 4, 2012 - Michael Ashbaugh
Stocks to watch Monday: AIG, AMD, BP 6:36 a.m. March 5, 2012 - MarketWatch
Medicis, PDL lead drug stocks north 11:47 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Santarus, Pharming tumble on FDA setback 10:11 a.m. Feb. 28, 2011 - Val Brickates Kennedy
Drug indexes diverge; BioSante falls 1:00 p.m. Dec. 28, 2010 - Val Brickates Kennedy

BofA Executive Nominated for Under Secretary Of Commerce and 2 Other Hot Stocks to Watch 11:47 a.m. Today - Wall St. Cheat Sheet
Salix Misses On Q3 Earnings; To Buy Santarus - Analyst Blog 11:30 a.m. Today - Zacks.com
The Deal: Salix Pharmaceuticals Buys Santarus for $2.6B 10:50 a.m. Today - TheStreet.com
Santarus (SNTS): Heavy Pre-Market Activity 8:28 a.m. Today - TheStreet.com
UPDATE: Piper Jaffray Downgrades Santarus Following Salix Acquisition Announcement 8:16 a.m. Today - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. Today - benzinga.com
Benzinga's Top Downgrades 6:17 a.m. Today - benzinga.com
Santarus Pharming, Announce New Data from Open-Label Repeat Treatment Study with RUCONEST 4:55 a.m. Today - benzinga.com
Salix Pharma to Acquire Santarus 6:18 p.m. Nov. 7, 2013 - TheStreet.com
Salix, Santarus Merging Into Billion-Dollar Drugmaker 5:38 p.m. Nov. 7, 2013 - Investors Business Daily
10-Q: SANTARUS INC 4:39 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Santarus Earnings Should Top 4 Hot Small-Cap Medicals 7:02 a.m. Nov. 7, 2013 - Investors Business Daily
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
5 Biotechnology Bargains With Attractive Fundamentals 1:06 a.m. Nov. 1, 2013 - Seeking Alpha
5 Top Fundamentals Stocks With Earnings Still On Tap 7:02 a.m. Oct. 31, 2013 - Investors Business Daily
Santarus to Present SAN-300 Phase I Data at 2013 American College of Rheumatology 6:04 a.m. Oct. 25, 2013 - benzinga.com
Interesting SNTS Put And Call Options For December 21st 11:10 a.m. Oct. 23, 2013 - TheStreet.com
Another Astute Deal For Depomed 9:38 a.m. Oct. 22, 2013 - Seeking Alpha
Insider Trading Alert - Santarus And 4 Others Traded By Insiders 11:45 a.m. Oct. 17, 2013 - TheStreet.com
BitAuto, Oasis Lead Big Earners With Top Fundamentals 7:02 a.m. Oct. 17, 2013 - Investors Business Daily

Santarus, Inc. and Salix Pharmaceuticals, Ltd. Merger May Not Be in Santarus, Inc. Shareholders' Best Interests 4:36 p.m. Today - PR Newswire
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Santarus, Inc. Stockholders 4:24 p.m. Today - BusinessWire
Law Offices of Howard G. Smith Announces Investigation of Santarus Inc. 1:38 p.m. Today - BusinessWire
Wolf Haldenstein Announces Investigation of Acquisition of Santarus, Inc. 12:36 p.m. Today - BusinessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Santarus, Inc. - SNTS 12:35 p.m. Today - PR Newswire
Santarus Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Salix Pharma 11:32 a.m. Today - BusinessWire
SANTARUS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Santarus, Inc. (SNTS) Over the Proposed Sale of the Company to Salix Pharmaceuticals Ltd. (SLXP) 11:12 a.m. Today - BusinessWire
Finkelstein Thompson LLP Announces Investigation of Santarus, Inc. Buyout Proposal 10:52 a.m. Today - BusinessWire
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Santarus, Inc. Proposed Acquisition by Salix Pharmaceuticals, Ltd. 10:34 a.m. Today - BusinessWire
SANTARUS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:33 a.m. Today - BusinessWire
Santarus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Salix Pharmaceuticals, Ltd. 10:17 a.m. Today - PR Newswire
Law Firm Brower Piven Announces Investigation of Santarus, Inc. Proposed Buyout 9:57 a.m. Today - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. 7:18 a.m. Today - BusinessWire
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST 1:00 a.m. Today - Thomson Reuters ONE
Santarus and Pharming Announce New Data from Open-Label Repeat Treatment Study with RUCONEST (Recombinant Human C1 Esterase Inhibitor) 1:00 a.m. Today - BusinessWire
The Law Firm of Wohl & Fruchter is Investigating the Acquisition of Santarus, Inc. by Salix Pharmaceuticals, Ltd. 7:20 p.m. Nov. 7, 2013 - BusinessWire
LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company In Connection With Sale Of the Company to Salix Pharmaceuticals, Ltd. 6:03 p.m. Nov. 7, 2013 - BusinessWire
Block & Leviton LLP Investigates Santarus, Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Salix Pharmaceuticals, Ltd. 5:59 p.m. Nov. 7, 2013 - PR Newswire
Santarus Reports Third Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - BusinessWire
Salix Pharmaceuticals Reports 3Q2013 Results 4:02 p.m. Nov. 7, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Insurance Bad Faith: Navigating California's Rigorous Laws

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

OneAscent Welcomes Monica Stoudemire as New CCO

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

XKL Delivers MediaLight for High-Speed Optical Transport

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Havoc, CSBC Partner for Autonomous Maritime Future

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Step Inside Henson's Creature Shop Magic in NYC

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Moore Law Investigates Aardvark Therapeutics' Risks

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...